These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27499787)

  • 1. Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.
    Abbasi MM; Valizadeh H; Hamishehkar H; Zakeri-Milani P
    Res Pharm Sci; 2016; 11(3):177-86. PubMed ID: 27499787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of clemastine on P-glycoprotein expression and function: an in vitro and in situ study.
    Abbasi MM; Valizadeh H; Hamishekar H; Mohammadnejad L; Zakeri-Milani P
    Iran J Basic Med Sci; 2016 Apr; 19(4):423-9. PubMed ID: 27279987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Cetirizine on P-glycoprotein Expression and Function In vitro and In situ.
    Mesgari Abbasi M; Valizadeh H; Hamishekar H; Mohammadnejad L; Zakeri-Milani P
    Adv Pharm Bull; 2016 Mar; 6(1):111-118. PubMed ID: 27123426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
    Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
    J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R; Surry DD; Smith VN; Gray AJ
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of in situ single pass perfusion model based on P-gp].
    Dong YL; Liu Y; Yin XW; Pan M; Li XL; Wang ZY; Dong L
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1539-1544. PubMed ID: 29071859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
    Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
    Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
    Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
    Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
    Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
    Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies.
    Zhang Y; Guo L; Huang J; Sun Y; He F; Zloh M; Wang L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    Tang F; Horie K; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
    Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
    Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
    Hoque MT; Kis O; De Rosa MF; Bendayan R
    Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay.
    Balimane PV; Chong S
    Int J Pharm; 2005 Sep; 301(1-2):80-8. PubMed ID: 16023314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.